Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › PCSK9 antagonist compounds

PCSK9 antagonist compounds

US Patent 11484565 · Granted Nov 1, 2022

Estimated economic value: $448,368,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Electronic devices with dual track dynamic voltage and frequency management2025
Diacylglyceride O-acyltransferase 2 inhibitors2025
Inhibitors of histone deacetylase useful for the treatment or prevention of HIV 2025
2-amino-n-phenyl-nicotinamides as NAV1.8 inhibitors2025
Inhibitors of histone deacetylase useful for the treatment or prevention of HIV 2025
Tetragalnac and peptide containing conjugates and methods for delivery of oligon2025
Inhibitors of histone deacetylase-3 useful for the treatment of cancer, inflamma2025
Dual-drug co-delivery system, preparation method therefor and use thereof2025
Substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (IDO) inhi2025
4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activi2025
4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activi2025
PCSK9 antagonist compounds2025